During the past decade, BlueClinical Phase I conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "BlueClinical Phase I" are "Non-Alcoholic Fatty Liver Disease" (1 trials), "Renal Impairment" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Smoking Cessation" (1 trials). Many other conditions were trialed in "BlueClinical Phase I" in a lesser frequency.

Most popular intervention types in "BlueClinical Phase I" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BAR502" (1 trials), "Cytisinicline" (1 trials), "FBL-MTX" (1 trials) and "Moxifloxacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "BlueClinical Phase I" are 4 trials for "All" genders.

Currently, there are NaN active trials in "BlueClinical Phase I". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in BlueClinical Phase I, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in BlueClinical Phase I, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".